Carolyn E Ragsdale

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Cerebrospinal Fluid

Recombinant Human

Systemic Lupus Erythematosus

Monoclonal Antibody

Top Venues

International journal of cancer

Open forum infectious diseases

Journal of pharmacy practice

This page only lists publications with an associated author ORCID identifier.

Publications

Carolyn E Ragsdale, Edwin P Rock
Adverse Drug Reaction vs Care Complication: Response to "Use of Colony-Stimulating Factors in Patients With Systemic Lupus Erythematous". Journal of pharmacy practice (2023)
Jaume Catala-Mora, Shakeel Modak, Joyce Kinsey, Carolyn E Ragsdale, Hillard M Lazarus
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma. International journal of cancer (2023)
Jaume Catala-Mora, Shakeel Modak, Joyce Kinsey, Carolyn E Ragsdale, Hillard M Lazarus
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma. International journal of cancer 154 (8) (2023)
Jaume Catala-Mora, Shakeel Modak, Joyce Kinsey, Carolyn E Ragsdale, Hillard M Lazarus
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma. International journal of cancer 154 (8) (2023)
Tempe K Chen, Jagmohan S Batra, David E Michalik, Jacqueline N Casillas, Ramesh Patel, Maritza E Ruiz, Harneet Hara, Bhavita Patel, Meena Kadapakkam, James H Ch'ng, Catherine B Small, Panagiotis Zagaliotis, Carolyn E Ragsdale, Luis O Leal, Emmanuel Roilides, Thomas J Walsh
Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases. Open forum infectious diseases 9 (11) (2022)